Nathan Windsor, DPM
Podiatrist · Hillsboro, ORNPI 1205298213
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,985 of the $5,659 with a category attached, or 88.1%. Stryker accounts for 64.8% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2021 at $1,576 and has fallen 61.8% since, to $601 in 2025.
Across 119 payments — averaging $47.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Smith+Nephew$544
- Mimedx Group, Inc.$277
- Organogenesis Inc.$262
- Kerecis Limited$172
- KCI USA, Inc.$83
- plus $654 from 19 others
What the payments were for
- Travel & lodging$67412%
- Food & beverage$4,98588%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 53 | $3,666 |
| Smith+Nephew | 15 | $544 |
| Mimedx Group, Inc. | 2 | $277 |
| Organogenesis Inc. | 9 | $262 |
| Kerecis Limited | 2 | $172 |
| KCI USA, Inc. | 5 | $83 |
| Treace Medical Concepts, Inc. | 3 | $68 |
| Paratek Pharmaceuticals, Inc. | 4 | $61 |
| Abbott | 1 | $57 |
| Integra Lifesciences Corporation | 2 | $56 |
| GRT US Holding, Inc. | 3 | $52 |
| Flower Orthopedics Coporation | 1 | $49 |
| Bioventus LLC | 3 | $42 |
| Orthofix Medical, Inc. | 4 | $40 |
| Johnson & Johnson | 1 | $38 |
| Nevro Corp. | 1 | $31 |
| Tactile Systems Technology Inc | 1 | $25 |
| DJO, LLC | 2 | $25 |
| Polynovo North America LLC | 1 | $24 |
| Checkpoint Surgical, Inc | 1 | $18 |
| Melinta Therapeutics, LLC | 1 | $16 |
| Hartmann USA, Inc. | 1 | $15 |
| Lightbody Medical Technologies Inc | 1 | $14 |
| Hydrofera LLC | 1 | $12 |
| Polarityte, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 SurgiClose$435
- PRIME SERIES$416
- GRAFIX PL$391
- Viaflow$323
- HOFFMANN$304
- INBONE$277
- AUGMENT INJECTABLE$175
- PROSTEP MICA$173
- PROPHECY$172
- ACTISHIELD CF$171
- SONICANCHOR$155
- AXSOS$149
- INVISION$145
- Kerecis Omega3 GraftGuide$145
- Kerecis Omega3 Marigen$145
- CARTIVA$122
- INFINITY$115
- Approach$104
How this compares
$5,659 in reported general payments places this provider in the 85th percentile of 74 podiatrist providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 11 | $4,370 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 132 | $1,104 |
| Lidocaine | 13 | $1,046 |
| Gabapentin | 55 | $595 |
| Doxycycline Hyclate | 37 | $352 |
| Ibuprofen | 44 | $346 |
| Ciclopirox | 14 | $252 |
| Methylprednisolone | 26 | $140 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $105 |
| Ammonium Lactate | 15 | $87 |
| Meloxicam | 39 | $37 |
| Prednisone | 11 | $25 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $544 | $4,37011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 74 podiatrist providers in Oregon.
Other podiatrist in Hillsboro
- Colin MizuoHillsboro$18K
- Heamin ShinHillsboro$205
- Rick McClureMedford$133K
- Cyaandi DoveGrand Ronde$51K
- Stephen SchroederTigard$28K
- Melinda NicholesPortland$15K
- Amanda KameryEugene$9K
- Peter PhamBeaverton$8K
- Liang-Chieh KoEugene$7K
- Kyle VillaruzGrants Pass$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.